SABRA HEALTH CARE REIT INC (SBRA) Fundamental Analysis & Valuation
NASDAQ:SBRA • US78573L1061
Current stock price
20.63 USD
-0.11 (-0.53%)
At close:
20.6139 USD
-0.02 (-0.08%)
After Hours:
This SBRA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. SBRA Profitability Analysis
1.1 Basic Checks
- In the past year SBRA was profitable.
- SBRA had a positive operating cash flow in the past year.
- The reported net income has been mixed in the past 5 years: SBRA reported negative net income in multiple years.
- SBRA had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- With a decent Return On Assets value of 2.83%, SBRA is doing good in the industry, outperforming 69.92% of the companies in the same industry.
- SBRA has a better Return On Equity (5.51%) than 65.04% of its industry peers.
- SBRA has a Return On Invested Capital of 3.88%. This is in the better half of the industry: SBRA outperforms 71.54% of its industry peers.
- SBRA had an Average Return On Invested Capital over the past 3 years of 3.71%. This is in line with the industry average of 3.11%.
- The last Return On Invested Capital (3.88%) for SBRA is above the 3 year average (3.71%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.83% | ||
| ROE | 5.51% | ||
| ROIC | 3.88% |
ROA(3y)1.83%
ROA(5y)0.45%
ROE(3y)3.54%
ROE(5y)0.95%
ROIC(3y)3.71%
ROIC(5y)3.47%
1.3 Margins
- SBRA has a Profit Margin of 20.09%. This is in the better half of the industry: SBRA outperforms 69.92% of its industry peers.
- SBRA's Profit Margin has declined in the last couple of years.
- SBRA's Operating Margin of 34.06% is fine compared to the rest of the industry. SBRA outperforms 70.73% of its industry peers.
- In the last couple of years the Operating Margin of SBRA has declined.
- Looking at the Gross Margin, with a value of 66.87%, SBRA is in line with its industry, outperforming 46.34% of the companies in the same industry.
- SBRA's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 34.06% | ||
| PM (TTM) | 20.09% | ||
| GM | 66.87% |
OM growth 3Y-3.2%
OM growth 5Y-4.77%
PM growth 3YN/A
PM growth 5Y-2.77%
GM growth 3Y-4.64%
GM growth 5Y-4.04%
2. SBRA Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SBRA is destroying value.
- Compared to 1 year ago, SBRA has more shares outstanding
- SBRA has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, SBRA has a worse debt to assets ratio.
2.2 Solvency
- SBRA has an Altman-Z score of 0.97. This is a bad value and indicates that SBRA is not financially healthy and even has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of 0.97, SBRA is in the better half of the industry, outperforming 74.80% of the companies in the same industry.
- A Debt/Equity ratio of 0.90 indicates that SBRA is somewhat dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.90, SBRA is in the better half of the industry, outperforming 61.79% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.9 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.97 |
ROIC/WACC0.54
WACC7.13%
2.3 Liquidity
- A Current Ratio of 1.48 indicates that SBRA should not have too much problems paying its short term obligations.
- SBRA's Current ratio of 1.48 is fine compared to the rest of the industry. SBRA outperforms 78.05% of its industry peers.
- SBRA has a Quick Ratio of 1.48. This is a normal value and indicates that SBRA is financially healthy and should not expect problems in meeting its short term obligations.
- With a decent Quick ratio value of 1.48, SBRA is doing good in the industry, outperforming 79.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.48 | ||
| Quick Ratio | 1.48 |
3. SBRA Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 20.75% over the past year.
- The Earnings Per Share has been decreasing by -0.91% on average over the past years.
- SBRA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.15%.
- SBRA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.29% yearly.
EPS 1Y (TTM)20.75%
EPS 3YN/A
EPS 5Y-0.91%
EPS Q2Q%-42.11%
Revenue 1Y (TTM)10.15%
Revenue growth 3Y7.43%
Revenue growth 5Y5.29%
Sales Q2Q%16.21%
3.2 Future
- The Earnings Per Share is expected to grow by 9.55% on average over the next years. This is quite good.
- Based on estimates for the next years, SBRA will show a quite strong growth in Revenue. The Revenue will grow by 11.91% on average per year.
EPS Next Y19.53%
EPS Next 2Y12.21%
EPS Next 3Y9.55%
EPS Next 5YN/A
Revenue Next Year11.05%
Revenue Next 2Y9.91%
Revenue Next 3Y8.54%
Revenue Next 5Y11.91%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. SBRA Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 32.23, which means the current valuation is very expensive for SBRA.
- Based on the Price/Earnings ratio, SBRA is valued a bit cheaper than 63.41% of the companies in the same industry.
- When comparing the Price/Earnings ratio of SBRA to the average of the S&P500 Index (25.79), we can say SBRA is valued slightly more expensively.
- SBRA is valuated quite expensively with a Price/Forward Earnings ratio of 26.97.
- SBRA's Price/Forward Earnings ratio is rather cheap when compared to the industry. SBRA is cheaper than 82.11% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 23.80. SBRA is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.23 | ||
| Fwd PE | 26.97 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, SBRA is valued a bit more expensive than the industry average as 63.41% of the companies are valued more cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 16.99 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.65
PEG (5Y)N/A
EPS Next 2Y12.21%
EPS Next 3Y9.55%
5. SBRA Dividend Analysis
5.1 Amount
- SBRA has a Yearly Dividend Yield of 5.77%, which is a nice return.
- SBRA's Dividend Yield is a higher than the industry average which is at 7.30.
- SBRA's Dividend Yield is rather good when compared to the S&P500 average which is at 1.91.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.77% |
5.2 History
- The dividend of SBRA decreases each year by -2.44%.
- SBRA has paid a dividend for at least 10 years, which is a reliable track record.
- SBRA has decreased its dividend recently.
Dividend Growth(5Y)-2.44%
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
- 186.04% of the earnings are spent on dividend by SBRA. This is not a sustainable payout ratio.
DP186.04%
EPS Next 2Y12.21%
EPS Next 3Y9.55%
SBRA Fundamentals: All Metrics, Ratios and Statistics
20.63
-0.11 (-0.53%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-12 2026-02-12/amc
Earnings (Next)05-04 2026-05-04
Inst Owners105.25%
Inst Owner Change6.77%
Ins Owners1.1%
Ins Owner Change6.9%
Market Cap5.20B
Revenue(TTM)774.63M
Net Income(TTM)155.61M
Analysts76
Price Target21.97 (6.5%)
Short Float %10%
Short Ratio8.88
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.77% |
Yearly Dividend1.18
Dividend Growth(5Y)-2.44%
DP186.04%
Div Incr Years0
Div Non Decr Years1
Ex-Date02-13 2026-02-13 (0.3)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-44.68%
Min EPS beat(2)-51.75%
Max EPS beat(2)-37.61%
EPS beat(4)1
Avg EPS beat(4)-10.49%
Min EPS beat(4)-51.75%
Max EPS beat(4)51.26%
EPS beat(8)2
Avg EPS beat(8)-12.84%
EPS beat(12)2
Avg EPS beat(12)-37.62%
EPS beat(16)3
Avg EPS beat(16)-70.46%
Revenue beat(2)1
Avg Revenue beat(2)6.1%
Min Revenue beat(2)-0.25%
Max Revenue beat(2)12.46%
Revenue beat(4)3
Avg Revenue beat(4)3.96%
Min Revenue beat(4)-0.25%
Max Revenue beat(4)12.46%
Revenue beat(8)7
Avg Revenue beat(8)2.98%
Revenue beat(12)8
Avg Revenue beat(12)2%
Revenue beat(16)10
Avg Revenue beat(16)1.09%
PT rev (1m)2.56%
PT rev (3m)3.38%
EPS NQ rev (1m)-4.76%
EPS NQ rev (3m)-7.15%
EPS NY rev (1m)-0.57%
EPS NY rev (3m)-2.91%
Revenue NQ rev (1m)6.17%
Revenue NQ rev (3m)4.79%
Revenue NY rev (1m)5.05%
Revenue NY rev (3m)2.2%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.23 | ||
| Fwd PE | 26.97 | ||
| P/S | 6.72 | ||
| P/FCF | N/A | ||
| P/OCF | 14.92 | ||
| P/B | 1.84 | ||
| P/tB | 1.89 | ||
| EV/EBITDA | 16.99 |
EPS(TTM)0.64
EY3.1%
EPS(NY)0.77
Fwd EY3.71%
FCF(TTM)-0.41
FCFYN/A
OCF(TTM)1.38
OCFY6.7%
SpS3.07
BVpS11.19
TBVpS10.93
PEG (NY)1.65
PEG (5Y)N/A
Graham Number12.69
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.83% | ||
| ROE | 5.51% | ||
| ROCE | 4.91% | ||
| ROIC | 3.88% | ||
| ROICexc | 3.93% | ||
| ROICexgc | 3.98% | ||
| OM | 34.06% | ||
| PM (TTM) | 20.09% | ||
| GM | 66.87% | ||
| FCFM | N/A |
ROA(3y)1.83%
ROA(5y)0.45%
ROE(3y)3.54%
ROE(5y)0.95%
ROIC(3y)3.71%
ROIC(5y)3.47%
ROICexc(3y)3.75%
ROICexc(5y)3.51%
ROICexgc(3y)3.78%
ROICexgc(5y)3.54%
ROCE(3y)4.7%
ROCE(5y)4.39%
ROICexgc growth 3Y5.81%
ROICexgc growth 5Y1.97%
ROICexc growth 3Y5.63%
ROICexc growth 5Y2.01%
OM growth 3Y-3.2%
OM growth 5Y-4.77%
PM growth 3YN/A
PM growth 5Y-2.77%
GM growth 3Y-4.64%
GM growth 5Y-4.04%
F-Score5
Asset Turnover0.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.9 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 5.61 | ||
| Cap/Depr | 242.22% | ||
| Cap/Sales | 58.47% | ||
| Interest Coverage | 2.38 | ||
| Cash Conversion | 77.32% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.48 | ||
| Quick Ratio | 1.48 | ||
| Altman-Z | 0.97 |
F-Score5
WACC7.13%
ROIC/WACC0.54
Cap/Depr(3y)121.85%
Cap/Depr(5y)94.04%
Cap/Sales(3y)30%
Cap/Sales(5y)24.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.75%
EPS 3YN/A
EPS 5Y-0.91%
EPS Q2Q%-42.11%
EPS Next Y19.53%
EPS Next 2Y12.21%
EPS Next 3Y9.55%
EPS Next 5YN/A
Revenue 1Y (TTM)10.15%
Revenue growth 3Y7.43%
Revenue growth 5Y5.29%
Sales Q2Q%16.21%
Revenue Next Year11.05%
Revenue Next 2Y9.91%
Revenue Next 3Y8.54%
Revenue Next 5Y11.91%
EBIT growth 1Y2.66%
EBIT growth 3Y4%
EBIT growth 5Y0.26%
EBIT Next Year84.04%
EBIT Next 3Y26.83%
EBIT Next 5Y18.61%
FCF growth 1Y-159.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.26%
OCF growth 3Y3.36%
OCF growth 5Y-0.36%
SABRA HEALTH CARE REIT INC / SBRA Fundamental Analysis FAQ
What is the ChartMill fundamental rating of SABRA HEALTH CARE REIT INC (SBRA) stock?
ChartMill assigns a fundamental rating of 4 / 10 to SBRA.
Can you provide the valuation status for SABRA HEALTH CARE REIT INC?
ChartMill assigns a valuation rating of 2 / 10 to SABRA HEALTH CARE REIT INC (SBRA). This can be considered as Overvalued.
How profitable is SABRA HEALTH CARE REIT INC (SBRA) stock?
SABRA HEALTH CARE REIT INC (SBRA) has a profitability rating of 5 / 10.
Can you provide the expected EPS growth for SBRA stock?
The Earnings per Share (EPS) of SABRA HEALTH CARE REIT INC (SBRA) is expected to grow by 19.53% in the next year.
How sustainable is the dividend of SABRA HEALTH CARE REIT INC (SBRA) stock?
The dividend rating of SABRA HEALTH CARE REIT INC (SBRA) is 5 / 10 and the dividend payout ratio is 186.04%.